Satellos Bioscience (TSX:MSCL) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:MSCL Satellos Bioscience Inc TSX:MSCL
35 GF Score
Price C$12.85
! 1 Warning Sign
View Full Analysis

What is Satellos Bioscience Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

TSX:MSCL
35GF Score
Satellos Bioscience Inc TSX:MSCL
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Satellos Bioscience Business Description

Other Exchanges MSLE:USA0IT:Germany
Address 200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
35GF Score

Get the complete analysis for TSX:MSCL

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$12.85
Price